---
$id: https://graph.org.ai/products/commodity/51372120
$type: Product
source: UNSPSC
code: "51372120"
title: "Dihydrocodeine thiocyanate"
class: "51372100"
classTitle: "Controlled substance analgesic morphine derivatives"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dihydrocodeine thiocyanate

**UNSPSC Code**: 51372120
**Class**: [Controlled substance analgesic morphine derivatives](Controlled substance analgesic morphine derivatives.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist and opioid C18H23NO3.CHNS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 442C0H2H3P, chemically known as morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, (5.alpha.,6.alpha.)-, thiocyanate (salt), but more generally known as dihydrocodeine thiocyanate, which bears US NIH Compound Identifier 46174078. European Medicines Agency schedules Dihydrocodeine thiocyanate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01707MIG. Most nations, for tariff and trade purposes, schedule dihydrocodeine thiocyanate under HS 29391100 and SITC 54141. As of Q4 2014, DIHYDROCODEINE THIOCYANATE remains US FDA's Preferred Term for this commodity. SMILES: CN1CC[C@]23C4C5CCC(C4O[C@H]2[C@H](CC[C@H]3[C@H]1C5)O)OC.C(=N)=S.

